Trung Huynh
Stock Analyst at RBC Capital
(4.87)
# 331
Out of 5,070 analysts
350
Total ratings
76.6%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Trung Huynh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 120.00 | CHF 126.50 | -5.14% | 15 | Oct 20, 2026 | |
| EPA: SAN Sanofi | Reiterated: Hold | €75.00 | €73.58 | +1.93% | 21 | Oct 20, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 14,500p | 12,618p | +14.92% | 19 | Oct 20, 2026 | |
| LLY Eli Lilly and Company | Reiterated: Buy | $1,500 | $1,283.66 | +16.85% | 32 | Oct 20, 2026 | |
| MRK Merck & Co. | Reiterated: Hold | $145 | $148.30 | -2.23% | 29 | Oct 20, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $280 | $289.08 | -3.14% | 18 | Oct 19, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Hold | $64 | $61.68 | +3.76% | 30 | Oct 19, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 1,975p | 1,869p | +5.70% | 18 | Oct 19, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | CHF 400.00 | CHF 389.90 | +2.59% | 17 | Oct 16, 2026 | |
| PFE Pfizer | Reiterated: Hold | $25 | $30.11 | -16.97% | 42 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 → $280 | $259.36 | +7.96% | 9 | Oct 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $595 → $660 | $807.48 | -18.26% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $25 | $0.4999 | n/a | 4 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $140 | $95.67 | n/a | 10 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $326 → $317 | $438.94 | n/a | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.2 → $1 | $1.24 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 → $38 | $30.29 | n/a | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $1.61 | n/a | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $12 | $6.04 | n/a | 2 | Mar 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.02 | n/a | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €10.00 → €13.50 | €10.16 | n/a | 9 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 700.00 → CHF 580.00 | CHF 625.00 | n/a | 3 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €44.00 → €40.00 | €53.00 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €14.00 → €12.00 | €10.34 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €105.00 | €151.90 | n/a | 6 | Apr 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €57.00 | €43.48 | n/a | 12 | Dec 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $7.54 | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €165.00 | €146.40 | n/a | 12 | May 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $70 | $39.35 | n/a | 3 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3.35 | $39.07 | n/a | 2 | Jun 25, 2020 |
Novartis AG
Oct 20, 2026
Reiterated: Hold
Price Target: CHF 120.00
Current: CHF 126.50
Upside: -5.14%
Sanofi
Oct 20, 2026
Reiterated: Hold
Price Target: €75.00
Current: €73.58
Upside: +1.93%
AstraZeneca PLC
Oct 20, 2026
Reiterated: Buy
Price Target: 14,500p
Current: 12,618p
Upside: +14.92%
Eli Lilly and Company
Oct 20, 2026
Reiterated: Buy
Price Target: $1,500
Current: $1,283.66
Upside: +16.85%
Merck & Co.
Oct 20, 2026
Reiterated: Hold
Price Target: $145
Current: $148.30
Upside: -2.23%
AbbVie
Oct 19, 2026
Reiterated: Buy
Price Target: $280
Current: $289.08
Upside: -3.14%
Bristol-Myers Squibb Company
Oct 19, 2026
Reiterated: Hold
Price Target: $64
Current: $61.68
Upside: +3.76%
GSK plc
Oct 19, 2026
Reiterated: Hold
Price Target: 1,975p
Current: 1,869p
Upside: +5.70%
Roche Holding AG
Oct 16, 2026
Reiterated: Buy
Price Target: CHF 400.00
Current: CHF 389.90
Upside: +2.59%
Pfizer
Oct 16, 2026
Reiterated: Hold
Price Target: $25
Current: $30.11
Upside: -16.97%
Oct 13, 2026
Reiterated: Buy
Price Target: $290 → $280
Current: $259.36
Upside: +7.96%
Nov 7, 2025
Reiterated: Hold
Price Target: $595 → $660
Current: $807.48
Upside: -18.26%
Aug 15, 2025
Reiterated: Buy
Price Target: $29 → $25
Current: $0.4999
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $133 → $140
Current: $95.67
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $326 → $317
Current: $438.94
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $1.2 → $1
Current: $1.24
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $44 → $38
Current: $30.29
Upside: n/a
Apr 1, 2025
Reiterated: Buy
Price Target: $10 → $7
Current: $1.61
Upside: n/a
Mar 29, 2025
Reiterated: Buy
Price Target: $13 → $12
Current: $6.04
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $4
Current: $2.02
Upside: n/a
Aug 24, 2023
Reiterated: Hold
Price Target: €10.00 → €13.50
Current: €10.16
Upside: n/a
Dec 7, 2022
Reiterated: Buy
Price Target: CHF 700.00 → CHF 580.00
Current: CHF 625.00
Upside: n/a
May 11, 2022
Reiterated: Sell
Price Target: €44.00 → €40.00
Current: €53.00
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: €14.00 → €12.00
Current: €10.34
Upside: n/a
Apr 13, 2022
Reiterated: Hold
Price Target: €105.00
Current: €151.90
Upside: n/a
Dec 13, 2021
Reiterated: Hold
Price Target: €57.00
Current: €43.48
Upside: n/a
Aug 4, 2021
Reiterated: Buy
Price Target: $28 → $30
Current: $7.54
Upside: n/a
May 13, 2021
Reiterated: Buy
Price Target: €165.00
Current: €146.40
Upside: n/a
Oct 12, 2020
Reiterated: Buy
Price Target: $54 → $70
Current: $39.35
Upside: n/a
Jun 25, 2020
Downgraded: Hold
Price Target: $3.35
Current: $39.07
Upside: n/a